scispace - formally typeset
I

Ian Mangion

Researcher at Merck & Co.

Publications -  79
Citations -  2001

Ian Mangion is an academic researcher from Merck & Co.. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 18, co-authored 67 publications receiving 1593 citations. Previous affiliations of Ian Mangion include Princeton University & California Institute of Technology.

Papers
More filters
Journal ArticleDOI

Enantioselective Organocatalytic Direct Aldol Reactions of α‐Oxyaldehydes: Step One in a Two‐Step Synthesis of Carbohydrates

TL;DR: This new aldol reaction provides an operationally simple protocol for the stereocontrolled production of polyol architectures and sets the stage for a twostep enantioselective carbohydrate synthesis.
Journal ArticleDOI

Total synthesis of brasoside and littoralisone.

TL;DR: Application of the two-step carbohydrate synthesis technology has enabled to access a selectively substituted glucose derivative for use as an intramolecular cycloaddition tether and serves to support the proposed biosynthetic origins of 1 from 2.
Journal ArticleDOI

The Importance of Iminium Geometry Control in Enamine Catalysis: Identification of a New Catalyst Architecture for Aldehyde–Aldehyde Couplings

TL;DR: This work has advanced the proline-catalysis concept to the first example of a direct enantioselective cross-coupling of aldehyde substrates (Scheme 1), a powerful yet elusive aldol variant that had previously only been carried out within the realm of enzymatic catalysis.
Journal ArticleDOI

A concise synthesis of a β-lactamase inhibitor.

TL;DR: A rapid synthesis featuring an iridium-catalyzed N-H insertion and a series of late stage transformations designed around the reactivity of the labile bicyclo at the core of the target are inspired.
Journal ArticleDOI

Iridium-Catalyzed X−H Insertions of Sulfoxonium Ylides

TL;DR: The unique reactivity of sulfoxonium ylides as a carbene source is described for a variety of X-H bond insertions, taking advantage of a simple, commercially available iridium catalyst, including a practical ring-expansion strategy for lactams.